Keywords: gsk, bi, license, sa, thembalami, make, arvs
GSK and BI license SA's Thembalami to make ARVs
Article | 19 July 2004
South Africa's Thembalami has been licensed by European drug majorsGlaxoSmithKline and Boehringer Ingelheim to make and sell generic antiretroviral drugs ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
